Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084954 · ClinicalTrials.gov registry record
Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 153
- Enrollment target
NCT01084954 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 153 participants.
The verdict
NCT01084954 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
Study Summary
Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive rate of \>1.0% would make this test unacceptable as a screening test for HIV viremia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01084954
The ClinicalTrials.gov registry entry for NCT01084954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01084954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01084954 about?
NCT01084954 is a clinical study titled "Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection". Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cephe...
What is the current status of trial NCT01084954?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2009-03. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01084954?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.